CopyMark Law Group
4.9/5
Drawing for DRUGZEVY

USPTO serial 99020963

DRUGZEVY

Reviewed by CopyMark Law Group

Reg. 8099101Status 700Registered
Filing date
Status date
Registration date
Jan 13, 2026
Examiner
WOOD,CAROLINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DRUGZEVY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Katherine P. Califa

Katherine P. Califa Foley & Lardner LLP3000 K Street, N.W.Sixth FloorWashington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
042Providing medical and scientific research information in the field of digital therapeutics services, neuromodulation therapy services, software as a medical device (samd), clinical trials, behavioral health services, custom design of computer software, and design and development of computer software, health care services for treating human health conditions, behaviors, and diseases using digital therapeutics; Providing technology and software development information in the fields of software as a medical device (samd), clinical trials, custom design of computer software and design and development of computer software; Providing medical and scientific research information in the field of clinical trialsACTIVENov 21, 2024
044Providing medical information to patients, medical professionals and pharmaceutical, medical and health care companies in the form of reports, white papers, predictive analytics, visualization and research results and studies in the field of digital therapeutics services, neuromodulation therapy services, behavior health services; Provision of health information in the field of health care services for neuromodulation therapy and treating human health conditions, behaviors and using digital therapeutics; Provision of medical information relating to neuromodulation therapy and treating human health conditions, behaviors and using digital therapeutics; Medical information provided via the internet; Providing healthcare information via the internet; Providing medical information in the fields of neuromodulation therapy and digital therapeutics via the InternetACTIVENov 21, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 30, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 16, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 16, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 10, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2025DOCKASSIGNED TO EXAMINER—
Jan 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 28, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 28, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance